Some types of human papillomavirus (HPV), the most common sexually transmitted viral infection, are high risk and can cause cervical cancer. Screening options for the prevention and early detection of cervical cancer depend on the age of the individual and may include cytology, cotesting, and primary high-risk HPV (hrHPV) testing. For women 25 to 30, two recommended cervical cancer screening options are available: primary hrHPV testing or cytology.
Having trouble viewing the algorithm? Go directly to the PDF